Assessment of the effects of gastric degradation-protected pea protein extract on mucosal satiety hormone release by human duodenal tissue - Protected pea protein extract and satiety hormone release

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 31 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Men/women, healthy human beings, age 18-70 years, BMI between 18.5 and 24.9 kg/m2, consistently stable body weight for at least 6 months (+/- 2 kg)

•Type 2 diabetes mellitus (defined as fasting plasma glucose >= 7.0 mmol/L); Gastroenterological diseases or abdominal surgery (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgment of the principle investigator); Cardiovascular diseases, cancer, liver or kidney malfunction, auto-immune diseases, disease with a life expectancy shorter than 5 years; Abuse of products; alcohol (>20 alcoholic consumptions per week) and drugs; Smoking; Plans to lose weight or following a hypocaloric diet; Use of any medication, including vitamin supplementation, except oral contraceptives, within 14 days prior to testing; Regular use of laxation products; Use of antibiotics in the 90 days prior to the start of study. Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 90 days prior to the study; Known pregnancy, lactation (checked by a pregnancy test before start of study); Blood donation within 3 months before study period; Self-admitted HIV-positive state

发起方

Medisch Universitair Ziekenhuis Maastricht